Recombinant Human USE1 Protein
Beta LifeScience
SKU/CAT #: BL-4334PS
Recombinant Human USE1 Protein
Beta LifeScience
SKU/CAT #: BL-4334PS
Catalog No.: BL-4334PS
Product Overview
| Tag | N/A |
| Host Species | Human |
| Synonym | Vesicle transport protein USE1, Putative MAPK-activatingprotein PM26, USE1-like protein, p31, USE1L, MDS032, Q-SNARE, SLT1, SNARE-LikeTail-Anchored Protein 1 Homolog, Protein P31. |
| Background | USE1Belongs to the USE1 family, this protein is a vesicle transport protein. USE1is a component of a SNAREcomplex consisting of STX18, USE1L, BNIP1/SEC20L and SEC22B. In additionUSE1 interacts directly with STX18. SNAREmay be involvedin targeting and fusion of Golgi-derived retrograde transport vesicles with theER. Diseases associated with USE1 comprise dysentery and hemolytic-uremicsyndrome. Among its related super-pathways are Nicotine Pathway (DopaminergicNeuron) and Pharmacodynamics. GO annotations related to this gene includeprotein binding. |
| Description | USE1 Human Recombinant expressed in E.Coli is a single, non-glycosylated polypeptide chain containing 254a.a. (1-231 a.a) and having a molecular weight of 28.3kDa. |
| Source | E.coli |
| AA Sequence | MGSSHHHHHH SSGLVPRGSH MGSMAASRLE LNLVRLLSRC EAMAAEKRDP DEWRLEKYVG ALEDMLQALKVHASKPASEV INEYSWKVDF LKGMLQAEKL TSSSEKALAN QFLAPGRVPT TARERVPATK TVHLQSRARYTSEMRSELLG TDSAEPEMDV RKRTGVAGSQ PVSEKQSAAE LDLVLQRHQN LQEKLAEEML GLARSLKTNT LAAQSVIKKD NQTLSHSLKMADQNLEKLKT ESERLEQHTQ KSVN |
| Purity | >80.0% as determined by SDS-PAGE. |
| Endotoxin | <1.0 EU per μg by the LAL method. |
| Formulation | USE1 protein solution (0.25mg/ml) containing 20mMTris-HCl buffer (pH8.0), 10% glycerol, 0.1M NaCl and 1mM DTT. |
| Stability | Recombinant protein is stable for 12 months at -70°C |
| Usage | For Research Use Only |
| Storage | Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Avoid multiple freeze-thaw cycles. |
